Áö¿¥ÇǾÆÀÌ´Â ´ëÇѹα¹ Á¦¾à¾÷°èÀÇ GMP Think-Tank¸¦ Ãß±¸ÇÕ´Ï´Ù. |
gmpeye ¡« home ¡« gmp guides & guidelines ¡« specialty services ¡« |
| ´º½º·¹ÅÍ
¹Ì±¹ FDAÀÇ GMP ½Ç»ç¿¡¼ ÁöÀûµÈ ½ÇÁ¦ »ç·Ê(FDA 483 ¶Ç´Â Warning Letter)¿Í GMP Á¤º¸ µîÀ» e-newsletter·Î Á¦°øÇÕ´Ï´Ù.
e-newsletter¸¦ ¹Þ°í ½ÍÀ¸½Å ºÐÀº ¾Æ·¡ ¿¬¶ôó·Î ½ÅÃ»ÇØ Áֽñ⠹ٶø´Ï´Ù.
gmpeye´Â °³ÀÎ Á¤º¸¸¦ ¼öÁýÇÏÁö ¾Ê½À´Ï´Ù. ±×·¯¹Ç·Î °£´ÜÇÏ°Ô "´º½º·¹ÅÍ ½Åû"À̶ó°í Á¦¸ñÀ» ½á¼ ¸ÞÀÏÀ» Áֽøé e-newsletter¸¦ º¸³»µå¸³´Ï´Ù. e-newsletter ¼ö½ÅÀ» ¿øÇÏÁö ¾Ê´Â ºÐÀº "´º½º·¹ÅÍ °ÅºÎ"¶ó°í Á¦¸ñÀ» ½á¼ ¸ÞÀÏÀ» ÁÖ½Ã¸é ¸®½ºÆ®¿¡¼ »èÁ¦ÇϰڽÀ´Ï´Ù.
½Åû: gmpeye@naver.com, gmpeye@hanmail.net, gmpeye@gmpeye.co.kr
¹Ì±¹ FDAÀÇ GMP ½Ç»ç »ç·Ê ¹®¼´Â GMP ¾÷¹«¸¦ °³¼±ÇÏ°í ±ÔÁ¦ ±â°üÀÇ GMP ½Ç»ç¸¦ ´ëºñÇϴµ¥ µµ¿òÀÌ µÇ¸®¶ó »ý°¢ÇÕ´Ï´Ù. GMP Case Study ¹®¼¸¦ Àμ⠰¡´ÉÇÑ PDF ÆÄÀÏ·Î ÆÇ¸ÅÇϰí ÀÖÀ¸´Ï, ±¸ÀÔÀ» ¿øÇϽô ºÐÀº ¾Æ·¡·Î ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù.
±¸ÀÔ ¹®ÀÇ: ±è¼¼Áß, ÀüÈ: 010-9950-4087 e-mail: gmpeye@naver.com, gmpeye@hanmail.net, gmpeye@gmpeye.co.kr
GMP Case Study: Lessons from FDA 483s & Warning Letters (~ 2015³â)
GMP Case Study: Lessons from FDA 483s & Warning Letters - Volume 1 (ÃÑ 156 ÆäÀÌÁö) GMP Case Study: Lessons from FDA 483s & Warning Letters - Volume 2 (ÃÑ 163 ÆäÀÌÁö) GMP Case Study: Lessons from FDA 483s & Warning Letters - Volume 3 (ÃÑ 155 ÆäÀÌÁö) GMP Case Study: Lessons from FDA 483s & Warning Letters - Volume 4 (ÃÑ 165 ÆäÀÌÁö) GMP Case Study: Lessons from FDA 483s & Warning Letters - Volume 5 (ÃÑ 154 ÆäÀÌÁö) GMP Case Study: Lessons from FDA 483s & Warning Letters - Volume 6 (ÃÑ 151 ÆäÀÌÁö) GMP Case Study: Lessons from FDA 483s & Warning Letters - Volume 7 (ÃÑ 216 ÆäÀÌÁö) GMP Case Study: Lessons from US FDA Warning Letters 2016 (ÃÑ 251 ÆäÀÌÁö) GMP Case Study: Lessons from US FDA Warning Letters 2017 (ÃÑ 378 ÆäÀÌÁö) GMP Case Study: Lessons from US FDA Warning Letters 2018 (ÃÑ 440 ÆäÀÌÁö) GMP Case Study: Lessons from US FDA Warning Letters 2019 (ÃÑ 429 ÆäÀÌÁö) GMP Case Study: Lessons from US FDA Warning Letters 2020 (ÃÑ 418 ÆäÀÌÁö) GMP Case Study: Lessons from US FDA Warning Letters 2021 (ÃÑ 451 ÆäÀÌÁö) GMP Case Study: Lessons from US FDA 483s 2020/2021 (ÃÑ 221 ÆäÀÌÁö) New GMP Case Study: Lessons from US FDA 483s 2022³â »ó¹Ý±â (ÃÑ 110 ÆäÀÌÁö) New
|
|
Copyright ¨Ï gmpeye. Since 2005. All rights reserved. |